Bill Riesner is an accomplished professional with extensive experience in market access and payer marketing, particularly within the diabetes and obesity sectors. Currently leading global market access strategy development for diabetes and obesity medications at Amgen since July 2024, Bill is also the Founder and CEO of Vonga, a company merging premium clothing and technology. Prior to these roles, Bill served at Eli Lilly and Company for two decades, where responsibilities included directing market access strategies for the incretin portfolio and overseeing successful product launches in diabetes pharmaceuticals and devices. Bill holds a JD from the Indiana University Robert H. McKinney School of Law, as well as an MBA and a Bachelor's degree in Business from the Indiana University - Kelley School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices